Acceptance and Completion Rates of 3-Month Isoniazid-Rifampicin (3HR) Tuberculosis Preventive Treatment (TPT) Among Contacts of Bacteriologically Confirmed TB Patients-Patients' and Healthcare Workers' Perspectives.

Autor: Ihesie A; United States Agency for International Development, Central Business District, Abuja 900211, Nigeria., Chukwuogo O; KNCV Nigeria, Central Business District, Abuja 900211, Nigeria., Eneogu R; United States Agency for International Development, Central Business District, Abuja 900211, Nigeria., Daniel OK; Institute of Human Virology Nigeria (IHVN), IHVN Towers, C00 Emeritus Umaru Shehu Ave, Cadastral, Abuja 900108, Nigeria., Agbaje A; Institute of Human Virology Nigeria (IHVN), IHVN Towers, C00 Emeritus Umaru Shehu Ave, Cadastral, Abuja 900108, Nigeria., Odume B; KNCV Nigeria, Central Business District, Abuja 900211, Nigeria., Nongo D; United States Agency for International Development, Central Business District, Abuja 900211, Nigeria., Ohikhuai C; Viamo Technologies Limited, Abuja 900108, Nigeria., Kadiri-Eneh N; KNCV Nigeria, Central Business District, Abuja 900211, Nigeria., Oyelaran O; United States Agency for International Development, Central Business District, Abuja 900211, Nigeria., Obianeri V; United States Agency for International Development, Central Business District, Abuja 900211, Nigeria., Van Gemert W; Stop TB Partnership, 1218 Geneva, Switzerland., Masini EO; Stop TB Partnership, 1218 Geneva, Switzerland., D'auvergne C; United States Agency for International Development Global Health Bureau, Washington, DC 20004, USA., Ochuko U; Federal Ministry of Health, Abuja 900108, Nigeria., Anyaike C; Federal Ministry of Health, Abuja 900108, Nigeria., Olarewaju SO; Department of Community Medicine, Osun State University, Osogbo 230101, Nigeria.

Publikováno v: Tropical medicine and infectious disease [Trop Med Infect Dis] 2024 Dec 07; Vol. 9 (12). Date of Electronic Publication: 2024 Dec 07.